BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
262 hedge funds and large institutions have $2.73B invested in bluebird bio in 2020 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 86 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
262
Holders Change
-13
Holders Change %
-4.73%
% of All Funds
4.65%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
46
Increased
93
Reduced
86
Closed
57
Calls
$45.9M
Puts
$49.1M
Net Calls
-$3.22M
Net Calls Change
-$4.62M
Top Buyers
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$36.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$24.6M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$18.8M |
| 4 |
JPMorgan Chase & Co
New York
|
+$18.5M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$18.5M |
